Latest Strategy Changes News

Sports Entertainment Group (SEG) reported a 62% jump in underlying EBITDA for FY25, underpinned by strong margin expansion and operational leverage. The company reaffirms its optimistic FY26 outlook with double-digit EBITDA growth expected.

Sports Entertainment Group Limited (SEG) reports a robust start to FY26 with a 63% jump in underlying EBITDA and advances its strategic exit from Perth Wildcats.

Finder Energy’s Kuda Tasi and Jahal oil development project in Timor-Leste received strong government endorsement and an independent resource upgrade, accelerating its path to first oil by 2027.

Element 25 Limited has announced significant progress in expanding its Butcherbird manganese mine and developing a US-based high-purity manganese refinery, backed by substantial government grants and strategic partnerships with automotive giants.

PPK Group reports record revenue at Craig International Ballistics and advances lithium sulfur battery technology, while preparing for a CEO transition and focusing on sovereign manufacturing.

MotorCycle Holdings Limited delivered a standout FY2025 with double-digit revenue and profit growth, underpinned by strong market share gains and operational efficiencies.

MotorCycle Holdings Limited reported a robust 2025 financial year with record revenue and profit growth, strengthened by key acquisitions that expanded its market share to 22%. The company’s focus on operational efficiency and digital transformation sets the stage for continued momentum in 2026.

Finaccess Restauración, S.L. has closed its takeover offer for Restaurant Brands New Zealand Limited, securing approximately 98% ownership and initiating compulsory acquisition of remaining shares ahead of the company’s delisting from NZX and ASX.

Maggie Beer Holdings reveals strategic progress in its 2025 AGM, focusing on operational simplification, financial stability, and targeted growth for its iconic brands.

InhaleRX Limited has announced a non-renounceable entitlement offer to raise approximately $247,668 by issuing nearly 10 million new shares at 2.5 cents each, accompanied by free attaching options. The offer opens on 5 December and closes on 17 December 2025.

InhaleRx Limited has introduced SRX-25, an oral fixed-dose combination therapy targeting Treatment-Resistant Depression, aiming to improve patient access and adherence. The company also secured $1 million in capital to advance clinical development and plans a strategic rebrand.

Hancock & Gore reports a statutory loss for FY25 amid major acquisitions and strategic transformation, setting sights on $200m revenue by FY27 as it rebrands to Schoolblazer Limited.